0001144204-17-048544.txt : 20170918
0001144204-17-048544.hdr.sgml : 20170918
20170918180253
ACCESSION NUMBER: 0001144204-17-048544
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170914
FILED AS OF DATE: 20170918
DATE AS OF CHANGE: 20170918
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fiorino Anthony S.
CENTRAL INDEX KEY: 0001608901
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36602
FILM NUMBER: 171090648
MAIL ADDRESS:
STREET 1: C/O BRAINSTORM CELL THERAPEUTICS, INC.
STREET 2: 605 THIRD AVENUE, 34TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMMUNE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001208261
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521841431
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 430 EAST 29TH STREET
STREET 2: SUITE 940
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 646-440-9310
MAIL ADDRESS:
STREET 1: 430 EAST 29TH STREET
STREET 2: SUITE 940
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: EPICEPT CORP
DATE OF NAME CHANGE: 20021129
4
1
v475391_form4.xml
FORM 4
X0306
4
2017-09-14
0
0001208261
IMMUNE PHARMACEUTICALS INC
IMNP
0001608901
Fiorino Anthony S.
C/O IMMUNE PHARMACEUTICALS INC.
550 SYLVAN AVENUE, SUITE 101
ENGLEWOOD CLIFFS
NJ
07632
0
1
0
0
Chief Medical Officer and COO
Stock Option
1.10
2017-09-14
4
A
0
90000
0
A
2017-09-14
2027-09-14
Common Stock
90000
90000
D
15% of the options shall vest ninety (90) days following the date of grant; 15% on the first-year anniversary of the date of grant (the "Anniversary") and 70% in equal portions at the end of each three (3) month period over the course of a two (2) year period commencing on the Anniversary.
/s/ Anthony Fiorino
2017-09-18